TAI'AN, China, March 22 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the
"Company"), a leading plasma-based biopharmaceutical company in
China, today announced that it
will host a conference call at 9:00 a.m.
EDT on Wednesday, March 24,
2010, to discuss the fourth quarter and full year 2009
financial results.
Hosting the call will be Mr. Colin
Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. The
Company plans to distribute its earnings press release prior to the
call.
To participate in the live conference call, please dial the
following number five to ten minutes prior to the scheduled
conference call time: 877-409-5468. International callers should
dial +1-702-894-2400. The pass code for the call is 64404888.
If you are unable to participate in the call at this time, a
replay will be available for 14 days starting on Wednesday, March 24, 2010 at 10:00 a.m. EDT. To access the replay, dial
800-642-1687, international callers should dial +1-706-645-9291.
The conference pass code is 64404888.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the "Company"), through its
indirect majority-owned subsidiaries, Shandong Taibang Biological
Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd,
and its equity investment in Xi'an Huitian Blood Products Co.,
Ltd., is currently the largest non-state-owned plasma-based
biopharmaceutical company in China. The Company is a fully integrated
biologic products company with plasma collection, production and
manufacturing, research and development, and commercial operations.
The Company's plasma-based biopharmaceutical products are
irreplaceable during medical emergencies, and are used for the
prevention and treatment of various diseases. The Company sells its
products to hospitals and other healthcare facilities in
China.
For more information, please contact:
Company Contact:
Mr. Y. Tristan Kuo
Chief Financial Officer
China Biologic Products, Inc.
Tel: +86-538-6202206
Email: IR@chinabiologic.com
Web: http://www.chinabiologic.com
Investor Relations Contact:
Ms. Lei Huang, Account Manager
CCG Investor Relations
Phone: +1-646-833-3417
Email: lei.huang@ccgir.com
Web: http://www.ccgirasia.com
Mr. Crocker Coulson, President
Phone: +1-646-213-1915
Email: crocker.coulson@ccgir.com
SOURCE China Biologic Products, Inc.